BofA raises Torrid stock price target on improved sales outlook By Investing.com

Torrid reported Q4 EPS of -$0.08 versus consensus -$0.13 (38.46% surprise) and revenue of $236.2M vs $230.89M forecast. Management guided FY2026 net sales of $940M–$960M and adjusted EBITDA of $65M–$75M; BofA raised its PT to $2.25, lifted FY2026/27 EBITDA estimates to $71M and $82M, and rolled valuation to FY2027 using a 6x EV/EBITDA. Shares are up 28% YTD but trade at $1.75 (52-week high $6.95) and slipped slightly after hours, signaling mixed market reception despite the beat and upgraded estimates.

Analysis

This name is a classic small-cap, niche-retailer story where a modest top-line recovery can flow disproportionately to the bottom line via fixed-cost leverage in SG&A — but the reverse is equally true. The next 2–4 quarters are binary: if same-store trends and inventory turns normalize, adjusted EBITDA can re-rate the capital structure; if not, promotional activity and markdowns will compress gross margins and rapidly erode any headline revenue beat.

Second-order winners include suppliers willing to reprice or extend terms to avoid concentrated exposure to a single retailer, and digital performance-marketing vendors that benefit as the company chases low-cost customer acquisition. Losers are mid-size mall-based apparel peers without the same niche loyalty: they will face traffic reallocation risk and likely be forced into promotional arms races if inventory overhang persists. Landlord concessions and vendor payment extensions are being used across the sector as quasi-liquidity — track changes there as telltales of stress or subtle balance-sheet relief.

Key catalysts on a 0–12 month clock are: weekly/monthly comps and inventory-to-sales trajectory; cadence on gross-margin restoration (promotions vs SKU-level cost recovery); and any capital raises or covenant amendments that would reset ownership economics. Tail risks: equity dilution, sudden liquidity squeeze, or a macro consumer retrenchment that flips the operating leverage dynamic within a single quarter.

Contrarian angle: consensus optimism assumes clean recovery of margin structure — what’s underappreciated is how modest improvements in repeat-purchase frequency and digital CAC can sustainably lift unit economics in the underserved plus-size segment. At the same time, small absolute misses in margin metrics will be punished harshly given the low-cap float; the prudent path is option-sized exposure to asymmetric upside with tight liquidity/ dilution protections.

Key Decisions for Investors

• Event-driven asymmetric: Buy a small, long-dated CURV call spread (12–15 month expiries) sized to 0.02% NAV — long a nearer-term 0.40–0.50 delta call and short a higher strike to fund — upside 2–4x if EBITDA recovery hits; max loss = premium paid. Rationale: captures re-rating while capping downside from binary dilution or operational slippage.
• Hedged equity starter: Build a micro long position in CURV equal to 0.05% NAV and pair with a notional short of the retail ETF XRT (size to neutralize broad retail beta) — set a hard stop-loss at 35–40% from entry and a 6–12 month target of +30–50% if margins stabilize. Rationale: isolates idiosyncratic recovery while hedging sector weakness.
• Protective structure for existing holders: Replace naked exposure with a collar—sell 3–6 month covered calls and buy 9–12 month protective puts to finance downside protection. Keep net cost low; this preserves upside capture to a re-rate while guarding against dilution-driven drawdowns.
• Risk-lite monitoring: Do not add materially ahead of the next public release of inventory and cash-burn data. Trigger to increase size: two consecutive months of improving gross-margin mix and decelerating promo cadence; trigger to exit or hedge further: disclosure of a planned capital raise or worsening inventory/sales ratio.